Sphingosine-1-phosphate transporter spinster homolog 2 is essential for iron-regulated metastasis of hepatocellular carcinoma

• DOI: 10.1016/j.ymthe.2021.09.012
• Publication Date: 2021-09-20T06:57:25Z
• Authors: Min Li; Yuxiao Tang; Dongyao Wang; Xiaofeng Zhai; Hui Shen; Chen Zhong; Man Yao; Aiguo Jin; Zhengjun Zhou; Shaolai Zhou; Jia Fan; Chang-quan Ling; Chen Ling
• Keywords: 0301 basic medicine; Carcinoma, Hepatocellular; Iron; Anion Transport Proteins; Liver Neoplasms; 3. Good health; Mice; 03 medical and health sciences; Cell Movement; Sphingosine; Cell Line, Tumor; Animals; Original Article; Lysophospholipids; Neoplasm Metastasis

Iron dyshomeostasis is associated with hepatocellular carcinoma (HCC) development. However, the role of iron in HCC metastasis is unknown. This study aimed to elucidate the underlying mechanisms of iron's enhancement activity on HCC metastasis. In addition to the HCC cell lines and clinical samples in vitro, iron-deficient (ID) mouse models were generated using iron-free diet and transferrin receptor protein knockout, followed by administration of HCC tumors through either orthotopic or ectopic route. Clinical metastatic HCC samples showed significant ID status, accompanied by overexpression of sphingosine-1-phosphate transporter spinster homolog 2 (SPNS2). Mechanistically, ID increased SPNS2 expression, leading to HCC metastasis in both cell cultures and mouse models. ID not only altered the anti-tumor immunity, which was indicated by phenotypes of lymphatic subsets in the liver and lung of tumor-bearing mice, but also promoted HCC metastasis in a cancer cell autonomous manner through the SPNS2. Since germline knockout of globe SPNS2 showed significantly reduced HCC metastasis, we further developed hepatic-targeting recombinant adeno-associated virus vectors to knockdown SPNS2 expression and to inhibit iron-regulated HCC metastasis. Our observation indicates the role of iron in HCC pulmonary metastasis and suggests SPNS2 as a potential therapeutic target for the prevention of HCC pulmonary metastasis.